CSP MYLAN SAS AT CSP LABO 274 — Sitagliptin Importer Profile
Pharmaceutical Importer · #18 buyer for Sitagliptin · $944.6K import value · 20 shipments · FRANCE · DGFT Verified
CSP MYLAN SAS AT CSP LABO 274 is the #18 importer of Sitagliptin from India with $944.6K in import value and 20 verified shipments. CSP MYLAN SAS AT CSP LABO 274 holds a 0.7% market share in Sitagliptin imports based in FRANCE. The company sources from 1 verified supplier across 10 formulations shipped to 2 countries. Overall, CSP MYLAN SAS AT CSP LABO 274 imports 6 pharmaceutical products worth $8.0M across 5 therapeutic categories.
CSP MYLAN SAS AT CSP LABO 274 — Sitagliptin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Sitagliptin to CSP MYLAN SAS AT CSP LABO 274?
Verified from 20 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MYLAN LABORATORIES LIMITED | $944.6K | 20 | 100.0% |
CSP MYLAN SAS AT CSP LABO 274 sources Sitagliptin from 1 verified Indian supplier based on 20 customs records. The primary supplier is MYLAN LABORATORIES LIMITED accounting for 100.0% of imports.
How Does CSP MYLAN SAS AT CSP LABO 274 Compare to Nearest Sitagliptin Importers?
Buyers ranked immediately above and below #18 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | XXAROXXPHAXXA SXX DXXC VX | MEXICO | $600.0K | 12 | $50.0K |
| 19 | MILPHARM LIMITED | UNITED KINGDOM | $550.0K | 11 | $50.0K |
| 18 | CSP MYLAN SAS AT CSP LABO 274 ★ | FRANCE | $500.0K | 10 | $50.0K |
CSP MYLAN SAS AT CSP LABO 274 ranks #18 among 575 Sitagliptin importers from India. Average shipment value of $50.0K compared to the market average of $44.6K. The closest competitors by value are XXAROXXPHAXXA SXX DXXC VX and MILPHARM LIMITED.
Where Does CSP MYLAN SAS AT CSP LABO 274 Import Sitagliptin To?
Destination countries from 20 verified shipments
CSP MYLAN SAS AT CSP LABO 274 imports Sitagliptin to 2 countries. The primary destination is FRANCE receiving 73.5% of shipments worth $694.6K.
What Sitagliptin Formulations Does CSP MYLAN SAS AT CSP LABO 274 Import?
| Formulation | Value | Shipments |
|---|---|---|
| SITAGLIPTINE VIATRIS 100 MG 28BL TAB PAC | $213.9K | 5 |
| SITAGLIPTIN TAB 100 MG 28 BL FR VIA PACK | $200.0K | 4 |
| SITAGLIPTINE VIATRIS 100 MG 28 BL TAB PA | $150.0K | 3 |
| HARMLESS MEDICINES, SITAGLIPTINE VIATRIS | $100.0K | 2 |
| SITAGLIPTIN TAB 100MG 28BL FR VIA TAB PA | $50.0K | 1 |
| SITAGLIPTINE VIATRIS 50 MG 28BL TAB (2X1 | $50.0K | 1 |
| SITAGLIPTINE VIATRIS 50 MG 28BL TAB PACK | $50.0K | 1 |
| SITAGLIPTINE VIATRIS 50 MG 28BL TAB PACKS 2X14S BLISTER 55898 PACKS X2X14S 1565144 NOS | $50.0K | 1 |
| SITAGLIPTINE VIATRIS 50 MG 28BL TAB PACKS 2X14S BLISTER 51515 PACKS X2X14S 1442420 NOS | $50.0K | 1 |
| SITAGLIPTINE VIATRIS 50 MG 28 BL TAB PAC | $30.6K | 1 |
CSP MYLAN SAS AT CSP LABO 274 imports 10 distinct Sitagliptin formulations from India. The top formulation is SITAGLIPTINE VIATRIS 100 MG 28BL TAB PAC with 5 shipments worth $213.9K.
Who Are the Top Buyers of Sitagliptin from India and How Much Does CSP MYLAN SAS AT CSP LABO 274 Import?
India exported $25.7M worth of Sitagliptin through 5,364 shipments from 309 suppliers to 121 countries, serving 575 buyers globally. CSP MYLAN SAS AT CSP LABO 274 imports $944.6K of this total, accounting for 0.7% of India's Sitagliptin exports with 20 shipments from FRANCE. This is verified from 20 customs shipment records covering 10 distinct formulations.
What Is the Average Order Value for CSP MYLAN SAS AT CSP LABO 274's Sitagliptin Imports?
CSP MYLAN SAS AT CSP LABO 274's average Sitagliptin order value is $47.2K per consignment, based on 20 shipments totaling $944.6K. CSP MYLAN SAS AT CSP LABO 274 is based in FRANCE and ranks #18 among all Sitagliptin importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Sitagliptin to CSP MYLAN SAS AT CSP LABO 274?
CSP MYLAN SAS AT CSP LABO 274 sources Sitagliptin from 1 verified Indian supplier: MYLAN LABORATORIES LIMITED ($944.6K, 100.0%). This is based on 20 customs records.
How Does CSP MYLAN SAS AT CSP LABO 274 Compare to Other Sitagliptin Importers?
CSP MYLAN SAS AT CSP LABO 274 ranks #18 among 575 Sitagliptin importers from India with a 0.7% market share. The top 3 importers are NEXT PHARMA LOGISTICS GMBH ($4.3M), SUDAIR PHARMA COMPANY ($3.2M), SANDOZ CANADA INC. C/O UPS SCS ($3.0M). CSP MYLAN SAS AT CSP LABO 274 processed 20 shipments from FRANCE.
What Other Diabetes & Endocrine Products Does CSP MYLAN SAS AT CSP LABO 274 Import?
CSP MYLAN SAS AT CSP LABO 274 also imports these diabetes & endocrine products. Each links to the detailed product page.
About CSP MYLAN SAS AT CSP LABO 274
CSP MYLAN SAS AT CSP LABO 274 imports 6 products worth $8.0M. Beyond Sitagliptin, top products include Metformin, Irbesartan, Hydrochlorothiazide, Ezetimibe, Terbinafine. View the complete CSP MYLAN SAS AT CSP LABO 274 profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Sitagliptin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Sitagliptin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: CSP MYLAN SAS AT CSP LABO 274 matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as CSP MYLAN SAS AT CSP LABO 274's capped import value divided by total capped export value for Sitagliptin across all Indian exporters.
- 5.Verified Records: This page is backed by 20 individual customs records matching CSP MYLAN SAS AT CSP LABO 274 importing Sitagliptin, covering 10 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 121+ countries, 575+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Sitagliptin Import Data for CSP MYLAN SAS AT CSP LABO 274
Access order-level details, pricing data, supplier connections, and competitive analysis for CSP MYLAN SAS AT CSP LABO 274's Sitagliptin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
CSP MYLAN SAS AT CSP LABO 274
Full Company Profile →
6 products · $8.0M total trade · 5 categories
CSP MYLAN SAS AT CSP LABO 274 × Sitagliptin
Verified from customs records
Company Overview
Top Products by CSP MYLAN SAS AT CSP LABO 274
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for CSP MYLAN SAS AT CSP LABO 274.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Sitagliptin. For current order-level data, contact TransData Nexus.